Jose-Carlos Gutiérrez-Ramos
Chief Tech/Sci/R&D Officer bij DANAHER CORPORATION
Vermogen: 4 M $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 jaar |
Matthew McGrew | M | 52 | - | |
Richard Shea | M | 72 | 21 jaar | |
Steven Rales | M | 72 | 41 jaar | |
Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 jaar |
Noubar Afeyan | M | 60 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | 6 jaar |
Rainer Blair | M | 60 | 14 jaar | |
Kevin Lee | M | 55 | 12 jaar | |
Santiago Arroyo | M | 64 | 7 jaar | |
Mitchell Rales | M | 67 | 41 jaar | |
Alistair Milnes | M | 50 | 3 jaar | |
Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 jaar |
Michael Skynner | M | 55 | 11 jaar | |
Michael Thomas Ropacki | M | - | 5 jaar | |
Jessica Mega | M | 49 | 5 jaar | |
Thomas J. Adam | M | - | 7 jaar | |
Christopher Bouda | M | 47 | 8 jaar | |
Stephen Sands | M | 67 | - | |
A. Sanders | M | 61 | 3 jaar | |
Brian Ellis | M | 58 | 8 jaar | |
Alan Spoon | M | 72 | 25 jaar | |
Travis Thompson | M | - | 6 jaar | |
Gregory Winter | M | 73 | 15 jaar | |
Teri List-Stoll | F | 61 | 13 jaar | |
Raymond Stevens | M | 60 | 7 jaar | |
Feroz Dewan | M | 47 | 2 jaar | |
Elias Zerhouni | M | 72 | 15 jaar | |
Thomas Freyman | M | 69 | 4 jaar | |
John Schwieters | M | 84 | 21 jaar | |
Peter Barrett | M | 71 | 7 jaar | |
Shantanu Narayen | M | 60 | 11 jaar | |
Walter Lohr | M | 80 | 41 jaar | |
Richard Kender | M | 68 | 5 jaar | |
Janice Bourque | F | 67 | 5 jaar | |
Jim Smith | M | 64 | 10 jaar | |
Linda Filler | F | 64 | 20 jaar | |
Helen Hobbs | M | 71 | 13 jaar | |
Travis Taylor | M | - | 3 jaar | |
A. JOSEPH ALEX | M | - | - | |
Carrie Strom | F | - | 4 jaar | |
Georgeann Couchara | F | 48 | 20 jaar | |
Steve Danehy | M | - | 12 jaar | |
Caroline Kurtz | M | - | 8 jaar | |
Jonathan Bryant | M | - | 4 jaar | |
Duane van Arsdale | M | - | 4 jaar | |
Susan Hohenleitner | F | - | 4 jaar | |
Nigel Crockett | M | 59 | 5 jaar | |
Zafar Qadir | M | - | 4 jaar | |
John Bedford | M | - | 3 jaar | |
Agnieszka Cieplinska | F | - | 5 jaar | |
Alex de Winter | M | - | 4 jaar | |
James Sutcliffe | M | 68 | 1 jaar | |
Nicholas Keen | M | 56 | 7 jaar | |
Pardis Sabeti | M | 48 | 5 jaar | |
Pascal Touchon | M | 61 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | - |
Sadik Kassim | M | - | 3 jaar | |
Pierre Legault | M | 63 | 5 jaar | |
William King | M | 56 | 26 jaar | |
James F. O'Reilly | M | - | - | |
David Berry | M | 47 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | - |
Elizabeth Gordon | M | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | - |
Jennifer Perry | F | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Simba Gill | M | 60 | 8 jaar | |
William Steere | M | 87 | 28 jaar | |
Jeffrey Kindler | M | 68 | 8 jaar | |
Craig Wheeler | M | 63 | 14 jaar | |
Michelle Robertson | F | 57 | 3 jaar | |
Ann Thorell | F | 56 | 1 jaar | |
David Epstein | M | 62 | 6 jaar | |
Ankit Mahadevia | M | 43 | 3 jaar | |
Alison D. Silva | F | 46 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 3 jaar |
Todd Shegog | M | 59 | 3 jaar | |
Louis J. Arcudi | M | 63 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | 7 jaar |
Ganesh Venkataraman Kaundinya | M | 57 | 17 jaar | |
Lee Kalowski | M | 43 | 6 jaar | |
Bruce Downey | M | 76 | 11 jaar | |
Alejandra Carvajal | F | 50 | 4 jaar | |
Lord Darzi | M | 63 | 5 jaar | |
Amy Schulman | F | 63 | 6 jaar | |
Marc Tessier-Lavigne | M | 64 | 4 jaar | |
Maiken Keson-Brookes | F | 52 | - | |
John Cox | M | 61 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | 3 jaar |
John Hohneker | M | 64 | 2 jaar | |
Luca Scavo | M | 57 | 1 jaar | |
David Perry | M | 56 | 6 jaar | |
Ronald O. Robison | M | - | - | |
Elizabeth Stoner | M | 73 | 13 jaar | |
Robert Landry | M | 60 | 4 jaar | |
Thomas Paul Koestler | M | 71 | 9 jaar | |
Theo Melas-Kyriazi | M | 64 | 6 jaar | |
Paul W. May | M | - |
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA. | - |
Olivier Brandicourt | M | 68 | 13 jaar | |
Bruce A. Leicher | M | 68 | 10 jaar | |
James Sulat | M | 73 | 11 jaar | |
Dana George Mead | M | 88 | 12 jaar | |
M. Anthony Burns | M | 81 | 25 jaar | |
Robert N. Burt | M | 86 | 11 jaar | |
Marsha Fanucci | F | 70 | 11 jaar | |
Georges Gemayel | M | 64 | 4 jaar | |
Scott Cundy | M | - | 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 86 | 86.00% |
Verenigd Koninkrijk | 16 | 16.00% |
Spanje | 1 | 1.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Jose-Carlos Gutiérrez-Ramos
- Persoonlijk netwerk